Kiwa Bio-Tech Revenues for 1st Half Exceed $3.... (to three termination agreementswith each...)

Kiwa Bio-Tech Revenues for 1st Half Exceed $3.25 Million

Date:8/19/2007

to three termination agreements with each party of the Urea entrepot trade for the termination of contracts between the Company and Shengkui Technologies, Hua Yang Roneo Corporation and UPB International Sourcing Limited. Pursuant to these termination agreements, the Company shall have neither rights nor obligations under previous contracts in connection with urea entrepot trade with exception to commission due to UPB. Based on these facts, we classified urea entrepot trade as discontinued operation and charged all unamortized payments and the remaining commission due into expenses in the second quarter.

Please refer to documents filed today with the Securities and Exchange Commission for additional information on the results for the second quarter and first half of 2007.

About Kiwa Bio-Tech Products Group Corporation

The Company develops, manufactures, distributes and markets innovative, cost-effective, and environmentally safe bio-technological products for agricultural and natural resources and environmental conservation. The Company's products are designed to enhance the quality of human life by increasing the value, quality and productivity of crops and decreasing the negative environmental impact of chemicals and other wastes. For more information about the Company, please review documents filed with the SEC (http://www.sec.gov) or visit the Company's website at http://www.kiwabiotech.com.

This press release contains information that constitutes forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Any such forward-looking statements involve risk and uncertainties that could cause actual results to differ materially from any future results described by the forward-looking statements. Risk factors that could contribute to such differences include those matters more
'/>"/>

SOURCE Kiwa Bio-Tech Products Group Corporation

1

GOOD

Page: 1 2 3 4 5 6
Related biology technology :

1. Industry Veterans take a look back from 2025: Bio-Technology, and Bio-Informatics are the focus
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports stronger earnings and revenues
4. Third Waves revenues rebound
5. Electronic signs for municipalities: Las Vegas or lost revenues?
6. TDS restates years of revenues, shows slight profit drop
7. Standard Networks reports 125% growth in software revenues
8. Catalyst International profit exceeds expectations
9. New report says Wisconsin R&D spending exceeding expectations
10. Submissions to the Gov.s Business Plan Contest Exceed Expectations
11. Venture Investors early-stage fund grows to $115 million

Post Your Comments:

Kiwa Bio-Tech Revenues for 1st Half Exceed $3....(to three termination agreementswith each...)